Non-invasive Glucose Monitoring Devices Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027
- Published: Jan 2023
- Pages: 157
- SKU: IRTNTR70187
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The non-invasive glucose monitoring devices market is estimated to grow at a CAGR of 15.68% between 2022 and 2027. The size of the market is forecast to increase by USD 22.49 million. The growth of the market depends on several factors, including the increasing prevalence of diabetes and the growing number of government programs, product launches, and, the increasing demand for non-invasive procedures.
This report extensively covers market segmentation by product (wearable and non-wearable), end-user (home care settings, hospitals, and clinics), and geography (North America, Europe, Asia, and Rest of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will be the size of the Non-invasive Glucose Monitoring Devices Market During the Forecast Period?
To learn more about this report, Download Report Sample
Parent Market Analysis
Technavio categorizes the global non-invasive glucose monitoring devices market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Non-invasive Glucose Monitoring Devices Market: Key Drivers, Trends, Challenges, and Customer Landscape
The increasing prevalence of diabetes and the growing number of government programs are notably driving the market growth, although factors such as high costs associated with non-invasive glucose monitoring devices may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Non-invasive Glucose Monitoring Devices Market Driver
The increasing prevalence of diabetes and the growing number of government programs for non-invasive treatments are the key factors driving the global non-invasive glucose monitoring devices non-invasive glucose meter market growth. The growing geriatric population is also a significant contributor to the diabetic population worldwide. Individuals in these age groups are sensitive to invasive diagnostic or monitoring procedures. These factors are significantly increasing the sales of non-invasive devices to monitor blood glucose levels. Genetic factors play an important role in the onset of diabetes.
Also, sedentary lifestyles such as physical inactivity and obesity are other factors responsible for the increasing prevalence of diabetes. Vendors are also launching new products to expand their product portfolios and improve their market visibility. The growing number of awareness programs to create awareness about preventive care and the regular monitoring of glucose levels for diabetes management will boost market growth during the forecast period.
Significant Non-invasive Glucose Monitoring Devices Market Trend
The integration of AI and RADAR technology in glucose monitoring will fuel the global non-invasive glucose monitoring devices non-invasive glucose meter market. The integration of data received from digital medical devices with mobile applications allows end-users to easily monitor body parameters, such as changes in glucose levels. Universities across the world are focusing on integrating AI and RADAR systems for monitoring and diagnosis of chronic diseases such as diabetes. Researchers are developing non-invasive glucose monitoring devices by combining RADAR and AI technologies, which would enable people with diabetes to monitor their blood glucose levels. Vendors are increasingly introducing innovative products to increase sales.
With the advent of technologies, such as AI and RADAR technology, many vendors are considering incorporating blood glucose monitoring devices with these technologies. Vendors are collaborating with IT companies for data management and the development of tools and software for easier diabetes management. Technologies will eliminate the need for finger pricking. Also, end-users can easily retrieve data. The integration of AI and RADAR technology in glucose monitoring devices is one of the key non-invasive blood glucose monitoring devices market trends.
Major Non-invasive Glucose Monitoring Devices Market Challenge
High costs associated with non-invasive glucose monitoring devices are a major challenge for the global non-invasive glucose monitoring devices market growth. The costs associated with non-invasive glucose monitoring are comparatively higher than the conventional blood glucose monitoring devices. This can increase the cost burden on patients. The average annual cost of non-invasive glucose monitoring devices ranges between USD 1,200 and USD 2,300, depending on the new technology and brand preference. It also increases with advanced technology integrated into the sensors. Non-invasive glucose monitoring devices comprise components such as patches, sensors, receivers, and transmitters.
They also need software tools that can capture data and send it to end users. This increases the overall cost of the complete system. The high costs associated with non-invasive glucose monitoring devices impact their adoption and coverage, especially in developing countries. Thus, the high cost of non-invasive glucose monitoring devices compared with conventional finger-pricking glucometers is a major hindering factor for the market growth during the forecast period.
Key Non-invasive Glucose Monitoring Devices Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Non-invasive Glucose Monitoring Devices Market Customer Landscape
Who are the Major Non-invasive Glucose Monitoring Devices Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
ascensiadiabetes.com - The company offers non-invasive glucose monitoring devices such as The Contour Next One. Also, through this segment, the company provides a wide range of devices for blood glucose monitoring and continuous glucose monitoring to help manage diabetes.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Abbott Laboratories
- BlueSemi
- BoydSense SAS
- Cnoga
- Dexcom Inc.
- DiaMonTech AG
- Eser Co.
- F. Hoffmann La Roche Ltd.
- Gluco Rx Ltd.
- GlucoTrack Inc.
- Informed Data Systems Inc. and One Drop.
- Medtronic Plc
- Meta Materials Inc.
- Nemaura Medical Inc.
- Platinum Equity Advisors LLC
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Non-invasive Glucose Monitoring Devices Market?
The market share growth by the wearable segment will be significant during the forecast period. In this segment, several start-ups are increasing their efforts by coming up with an innovative product pipeline, which is likely to spur the growth of the segment during the forecast period. Therefore, a strong product pipeline by new vendors, continuous technological advancements by key vendors, and the growing demand for non-invasive monitoring of glucose levels is likely to augment the demand for wearable non-invasive glucose monitoring devices, which, in turn, will drive the growth of the market during the forecast period
Get a glance at the market contribution of various segments Request a PDF Sample
The wearable segment was valued at USD 8.70 million in 2017 and continue to grow by 2021. Wearable non-invasive glucose monitoring devices comprise transdermal sensors that pass a near-infrared (NI) light through the skin layer to measure glucose levels using optical approaches. The wearable product segment accounts for the largest market share in the global non-invasive glucose monitoring devices market. Factors such as the increasing prevalence of diabetes, technological advancements, the presence of strong vendors, and new product launches will boost the growth of the segment during the forecast period.
Which are the Key Regions for the Non-invasive Glucose Monitoring Devices Market?
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 49% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The non-invasive glucose monitoring devices market in North America will grow at a moderate rate during the forecast period. Factors such as the increasing prevalence of diabetes, the rising number of product launches, the growing presence of regional and global vendors, and initiatives by government and non-profit organizations to create awareness about diabetes prevention and management are boosting the market growth in North America. Moreover, patients with diabetes require glucose meters to monitor their glucose levels. The rising prevalence of diabetes will increase the need for glucose meters, which, in turn, will augment the adoption of non-invasive glucose monitoring devices during the forecast period.
In 2020, with the outbreak of COVID-19, the regional non-invasive glucose monitoring devices market registered low growth. However, in the first half of 2021, with the gradual decrease in COVID-19 cases, lockdowns were lifted, leading to the resumption of non-essential services in hospitals, health clinics, and manufacturing units. Such factors will fuel the demand for non-invasive glucose monitoring devices, which, in turn, will drive the growth of the regional market during the forecast period.
Segment Overview
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
- Product Outlook (USD Million, 2017 - 2027)
- Wearable
- Non-wearable
- End-user Outlook (USD Million, 2017 - 2027)
- Home care settings
- Hospitals
- Clinics
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Australia
- Argentina
- Rest of the Middle East & Africa
- North America
|
Non-invasive Glucose Monitoring Devices Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
157 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 15.68% |
|
Market growth 2023-2027 |
USD 22.49 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
14.06 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 49% |
|
Key countries |
US, Germany, UK, India, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., F. Hoffmann La Roche Ltd., Gluco Rx Ltd., GlucoTrack Inc., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Non-invasive Glucose Monitoring Devices Market Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the non-invasive glucose monitoring devices market between 2023 and 2027
- Precise estimation of the size of the non-invasive glucose monitoring devices market size and its contribution to the parent market
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about vendors
- Comprehensive analysis of factors that will challenge the growth of non-invasive glucose monitoring devices market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global non-invasive glucose monitoring devices market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global non-invasive glucose monitoring devices market 2017 - 2021 ($ million)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.3 End-User Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Wearable - Market size and forecast 2022-2027
- Exhibit 34: Chart on Wearable - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Wearable - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Wearable - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Wearable - Year-over-year growth 2022-2027 (%)
- 6.4 Non-wearable - Market size and forecast 2022-2027
- Exhibit 38: Chart on Non-wearable - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Non-wearable - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Non-wearable - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Non-wearable - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Home care settings - Market size and forecast 2022-2027
- Exhibit 47: Chart on Home care settings - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Data Table on Home care settings - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Chart on Home care settings - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Home care settings - Year-over-year growth 2022-2027 (%)
- 7.4 Hospitals - Market size and forecast 2022-2027
- Exhibit 51: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
- 7.5 Clinics - Market size and forecast 2022-2027
- Exhibit 55: Chart on Clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Clinics - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Clinics - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Clinics - Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by End-user
- Exhibit 59: Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 61: Chart on Market share by geography 2022-2027 (%)
- Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 63: Chart on Geographic comparison
- Exhibit 64: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 UK - Market size and forecast 2022-2027
- Exhibit 89: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.10 India - Market size and forecast 2022-2027
- Exhibit 93: Chart on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on India - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on India - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on India - Year-over-year growth 2022-2027 (%)
- 9.11 China - Market size and forecast 2022-2027
- Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 101: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 102: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 104: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 105: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 106: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 107: Matrix on vendor position and classification
- 12.3 Abbott Laboratories
- Exhibit 108: Abbott Laboratories - Overview
- Exhibit 109: Abbott Laboratories - Business segments
- Exhibit 110: Abbott Laboratories - Key news
- Exhibit 111: Abbott Laboratories - Key offerings
- Exhibit 112: Abbott Laboratories - Segment focus
- 12.4 Ascensia Diabetes Care Holdings AG
- Exhibit 113: Ascensia Diabetes Care Holdings AG - Overview
- Exhibit 114: Ascensia Diabetes Care Holdings AG - Product / Service
- Exhibit 115: Ascensia Diabetes Care Holdings AG - Key offerings
- 12.5 BoydSense SAS
- Exhibit 116: BoydSense SAS - Overview
- Exhibit 117: BoydSense SAS - Product / Service
- Exhibit 118: BoydSense SAS - Key offerings
- 12.6 Cnoga
- Exhibit 119: Cnoga - Overview
- Exhibit 120: Cnoga - Product / Service
- Exhibit 121: Cnoga - Key offerings
- 12.7 Dexcom Inc.
- Exhibit 122: Dexcom Inc. - Overview
- Exhibit 123: Dexcom Inc. - Product / Service
- Exhibit 124: Dexcom Inc. - Key news
- Exhibit 125: Dexcom Inc. - Key offerings
- 12.8 DiaMonTech AG
- Exhibit 126: DiaMonTech AG - Overview
- Exhibit 127: DiaMonTech AG - Product / Service
- Exhibit 128: DiaMonTech AG - Key offerings
- 12.9 F. Hoffmann La Roche Ltd.
- Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
- 12.10 GlucoTrack Inc.
- Exhibit 134: GlucoTrack Inc. - Overview
- Exhibit 135: GlucoTrack Inc. - Product / Service
- Exhibit 136: GlucoTrack Inc. - Key offerings
- 12.11 Medtronic Plc
- Exhibit 137: Medtronic Plc - Overview
- Exhibit 138: Medtronic Plc - Business segments
- Exhibit 139: Medtronic Plc - Key news
- Exhibit 140: Medtronic Plc - Key offerings
- Exhibit 141: Medtronic Plc - Segment focus
- 12.12 Meta Materials Inc.
- Exhibit 142: Meta Materials Inc. - Overview
- Exhibit 143: Meta Materials Inc. - Key offerings
- 12.13 Nemaura Medical Inc.
- Exhibit 144: Nemaura Medical Inc. - Overview
- Exhibit 145: Nemaura Medical Inc. - Product / Service
- Exhibit 146: Nemaura Medical Inc. - Key offerings
- 12.14 Platinum Equity Advisors LLC
- Exhibit 147: Platinum Equity Advisors LLC - Overview
- Exhibit 148: Platinum Equity Advisors LLC - Product / Service
- Exhibit 149: Platinum Equity Advisors LLC - Key offerings
- 12.15 Rite Aid Corp.
- Exhibit 150: Rite Aid Corp. - Overview
- Exhibit 151: Rite Aid Corp. - Key offerings
- 12.16 Taiwan Biophotonic Co.
- Exhibit 152: Taiwan Biophotonic Co. - Overview
- Exhibit 153: Taiwan Biophotonic Co. - Product / Service
- Exhibit 154: Taiwan Biophotonic Co. - Key offerings
- 12.17 Walgreens Boots Alliance Inc.
- Exhibit 155: Walgreens Boots Alliance Inc. - Overview
- Exhibit 156: Walgreens Boots Alliance Inc. - Business segments
- Exhibit 157: Walgreens Boots Alliance Inc. - Key offerings
- Exhibit 158: Walgreens Boots Alliance Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 159: Inclusions checklist
- Exhibit 160: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 161: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 162: Research methodology
- Exhibit 163: Validation techniques employed for market sizing
- Exhibit 164: Information sources
- 13.5 List of abbreviations
- Exhibit 165: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Germany
- UK
- India
- China
- Increasing prevalence of diabetes and growing number of government programs
- Growing focus on collaborations for business expansion
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
